Gauthier Pouliquen

Chief Executive Officer @Pk Med

Lyon, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Apr 2023 — Present

Chief Executive Officer @Pk Med

View department →

Lyon, FR

EDUCATION

N/A

Pierre and Marie Curie University

Ph.D.

ABOUT GAUTHIER POULIQUEN

I am the CEO & CTO of PK MED, a French innovative biotech developing highly effective and safe tissue-targeted therapies in rheumatology and tissue regeneration.Our lead asset, PKM-01, a first-in-class intra-articular injection for gout flares treatment, is FDA and EMA-cleared for direct Phase 2 entry. Based on the first ever intra-articular colchicine administration, it offers immediate and sustained pain relief with superior safety, addressing a critical market need.Our second asset, PKM-02, pioneers an innovative cell-homing strategy to enhance bone marrow transplantation, a curative treatment for leukemias and hematologic diseases.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Gauthier Pouliquen — Chief Executive Officer at Pk Med in Lyon, FR | Unifers